Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
IBP-9414 by Infant Bacterial Therapeutics for Necrotizing Enterocolitis: Likelihood of Approval
IBP-9414 is under clinical development by Infant Bacterial Therapeutics and currently in Phase III for Necrotizing Enterocolitis. According to GlobalData,...